Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence NGDDGEAGKPGRPGERGPPGP
Primary information
sequence IDSeq_5610
Peptide sequenceNGDDGEAGKPGRPGERGPPGP
CancerPDF_ID CancerPDF_ID10857, CancerPDF_ID10859,
PMID21805675,21805675
Protein NameCollagen alpha-1(I) chain,Collagen alpha-1(I) chain
UniprotKB Entry NameCO1A1_HUMAN,CO1A1_HUMAN
FluidUrine,Urine
M/Z2048.9342,2064.9331
ChargeNA,NA
Mass (in Da)NA,NA
fdrNA,NA
Profiling TechniqueMALDI-TOF,MALDI-TOF
Peptide Identification techniqueMALDI-TOF-MS,MALDI-TOF-MS
Quantification TechniqueNA,NA
Labelled/Label FreeLabel Free,Label Free
FDR1,1
CancerPDF_ID CancerPDF_ID10857, CancerPDF_ID10859,
p-ValueNA,NA
SoftwareNA,NA
Length21,21
Cancer TypeMuscle-invasive bladder cancer,Muscle-invasive bladder cancer
DatabaseSwissProt Database,SwissProt Database
Modification"Oxidation: 13, 21","Oxidation: 10, 13, 21"
Number of Patients751 bladder cancer and 127 control,751 bladder cancer and 127 control
RegulationDifferentially expressed between cancer vs normal samples,Differentially expressed between cancer vs normal samples
ValidationMann-Whitney tests and areas under receiver-operator characteristic,Mann-Whitney tests and areas under receiver-operator characteristic
SensitivityNA,NA
SpecificityNA,NA
AccuracyNA,NA
Peptide AtlasNA
IEDB
Primary information
sequence IDSeq_5615
Peptide sequenceNGDDGEAGKpGRPGERGpPGp
CancerPDF_ID CancerPDF_ID3703,
PMID27026199
Protein NameCollagen alpha-1(I) chain
UniprotKB Entry NameCO1A1_HUMAN
FluidUrine
fdr2063.93
Profiling Technique"CE-MS, Micro-TOF-MS"
Peptide Identification techniqueMS-MS
Labelled/Label FreeLabel Free
CancerPDF_ID CancerPDF_ID3703,
p-Valueless than 0.05
SoftwareProteome Discoverer 1.2
Length21
Cancer TypeBladder cancer
DatabaseUniprot Human non-redundant Database
Modificationp:Hydroxy-Proline
Number of Patients 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls)
RegulationDifferentially expressed between recurrence of UBC vs recurrence control
ValidationIndependent Validation
SensitivityFor testing dataset 88%
SpecificityFor testing dataset 51%
AccuracyNA
Peptide AtlasNA
IEDBNA
Primary information
sequence IDSeq_5616
Peptide sequenceNGDDGEAGKpGRpGERGPPGP
CancerPDF_ID CancerPDF_ID3702,
PMID27026199
Protein Name"Collagen alpha-1(I) chain, Collagen alpha- 1(I) chain (Alpha-1 type I collagen)"
UniprotKB Entry NameCO1A1_HUMAN
FluidUrine
fdr2047.93
Profiling Technique"CE-MS, Micro-TOF-MS"
Peptide Identification techniqueMS-MS
Labelled/Label FreeLabel Free
CancerPDF_ID CancerPDF_ID3702,
p-Valueless than 0.05
SoftwareProteome Discoverer 1.2
Length21
Cancer TypeBladder cancer
DatabaseUniprot Human non-redundant Database
Modificationp:Hydroxy-Proline
Number of Patients 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls)
RegulationDifferentially expressed between recurrence of UBC vs recurrence control
ValidationIndependent Validation
SensitivityFor testing dataset 88%
SpecificityFor testing dataset 51%
AccuracyNA
Peptide AtlasNA
IEDBNA